![]() 102000007312 Recombinant Proteins Human genes 0.000 claims abstract description 62.108010033725 Recombinant Proteins Proteins 0.000 claims abstract description 62. ![]() 239000000725 suspension Substances 0.000 claims abstract description 90.239000001963 growth media Substances 0.000 claims abstract description 130.239000000203 mixture Substances 0.000 claims abstract description 222.108090000623 proteins and genes Proteins 0.000 title claims description 240.102000004169 proteins and genes Human genes 0.000 title claims description 240.230000014509 gene expression Effects 0.000 title claims abstract description 397.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US201562191969P priority Critical Priority to US62/191,969 priority Application filed by Life Technologies Corporation filed Critical Life Technologies Corporation Publication of WO2017011598A1 publication Critical patent/WO2017011598A1/en Links Inventor Jonathan Zmuda Chao Yan Liu Original Assignee Life Technologies Corporation Priority date (The priority date is an assumption and is not a legal conclusion. Google Patents WO2017011598A1 - System and method for improved transient protein expression in cho cells See all webcasts from Gibco ExpressionWorld virtual eventĪccess a curated list of publications that highlights the advantages of our Expi protein expression systems.WO2017011598A1 - System and method for improved transient protein expression in cho cells.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |